Why Purity Won't Show Whether a Peptide Has Clumped Together in Solution

Why Purity Won't Show Whether a Peptide Has Clumped Together in Solution

Subheadline: An HPLC purity number tells you how clean the intended sequence is. It says nothing about whether those molecules float apart as monomers or stick together as aggregates, so labs turn to two size-based instruments that each see a different slice of the problem.

A certificate of analysis can read 98 percent purity and still tell you almost nothing about the physical state of the vial.

That sentence sounds contradictory until you separate two questions that look alike.

One question is chemical: is the material in this vial mostly the intended sequence, free of truncations and deletions? A reverse-phase HPLC area-percent answers that reasonably well.

The other question is physical: when those molecules are dissolved, do they stay apart as individual monomers, or do they clump into pairs, chains, and larger clusters? Purity does not answer that at all.

The two instruments that do answer it do not agree by default, because each one looks through a different window.

What aggregation actually is

Aggregation is self-association. Molecules meet in solution and stick together through hydrophobic patches, electrostatic attraction, or hydrogen bonding, forming dimers, trimers, oligomers, and eventually large clusters.

Whether they stick depends on the environment, not just the sequence. Concentration, pH, salt, temperature, and the solvent all tilt the balance between a clean monomer population and a clumpy one. The same peptide can be monodisperse in one buffer and aggregated in another.

For a research lab this is a reproducibility question, not an abstract one. A sample that has aggregated scatters light differently, migrates differently, and interacts differently in downstream experiments. If two groups run the same peptide but one has a monomer stock and the other an oligomer stock, their results will not line up. That is why physical state gets its own battery of tests, separate from purity.

The default tool: size-exclusion chromatography

Size-exclusion chromatography, or SEC, separates molecules by size rather than by chemistry. A sample is pushed through a column packed with porous beads. Small molecules slip in and out of the pores, so they travel a long, winding path and arrive late. Large molecules cannot enter the pores, so they take the short route and elute first.

That size ordering is why SEC is the workhorse for aggregate testing in research and in biopharmaceutical quality control. It is fast, reproducible, and needs no harsh solvents. A monomer, a dimer, and a high-order oligomer can, in principle, show up as separate peaks.

But SEC carries well-documented blind spots.

The largest aggregates all arrive together in the column's void volume, so you cannot tell whether you have one giant species or many. Some aggregates adsorb to the column packing and never come off, which quietly under-reports the true amount. Aggregates larger than the column inlet can be filtered out before they ever get inside. And because the sample is diluted and pushed through a new environment, aggregates can fall apart or form during the run itself, leaving a chromatogram that may not reflect what was in the vial when you started.

None of this is hypothetical. A 2010 paper by John Carpenter and colleagues addressed this exact problem, laying out each failure mode and arguing that SEC results should be checked against an independent, orthogonal method.

The complementary tool: dynamic light scattering

Dynamic light scattering, or DLS, skips the column entirely. It shines a laser through the sample and watches how rapidly the scattered light flickers.

That flicker comes from Brownian motion, the random jostling of particles in a liquid. Big particles jostle slowly, so the light flickers slowly. Small particles jostle fast. By timing the fluctuations, DLS works out a diffusion coefficient and converts it through the Stokes-Einstein relation into a hydrodynamic radius.

The striking property is sensitivity. Scattered intensity rises with the sixth power of particle size, so a handful of large aggregates can out-shine an ocean of monomers. That makes DLS superb at spotting trace aggregation that SEC might dilute away or miss, and it works in the sample's own buffer with no column interaction at all.

The trade-off is resolution. DLS struggles to separate a monomer from a dimer or a trimer. As the Harvard Center for Macromolecular Interactions notes, the technique is unlikely to resolve small oligomers from the monomer, and mixtures tend to appear as one broad peak. DLS tells you something aggregated, but not cleanly how big the pieces are.

Why the two need each other

SEC excels at resolving and quantifying a dimer or trimer peak but can miss material that sticks to the column or hides in the void volume. DLS catches trace large aggregates but smears small oligomers together. They are complements, not substitutes.

That is why the strongest setups couple them. SEC-MALS runs a size-exclusion column into a multi-angle light scattering detector, so each resolved peak gets an absolute molar mass from first principles, independent of how long it took to elute. The result is a picture of aggregation that no single ultraviolet peak could give.

Read the number for what it is

The next time you see "99 percent pure" on a datasheet, read it for what it says: this is a statement about chemical composition, not about whether the molecules stay apart in solution. Aggregation state is a separate property, measured with separate tools, each with its own window and its own blind spot.

If physical state matters to your experiment, the question is not simply "is this pure." It is "which method was used to assess aggregation, and was it checked against a second one."

Want a plain-language walkthrough of how to read the analytical documentation that accompanies a research peptide, or a request for the available batch documentation? Those are questions we can answer without guessing.

For research use only. Not for human or veterinary consumption.

Sources

• Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJA, Middaugh CR, Winter G. "Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products." Journal of Pharmaceutical Sciences. 2010;99(5):2200-2208. doi:10.1002/jps.21989. https://pubmed.ncbi.nlm.nih.gov/19918982/

• Hong P, Koza S, Bouvier ESP. "Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates." Journal of Liquid Chromatography & Related Technologies. 2012;35(20):2923-2950. doi:10.1080/10826076.2012.743724. https://pmc.ncbi.nlm.nih.gov/articles/PMC3556795/

• Lorber B, Fischer F, Bailly M, Roy H, Kern D. "Protein analysis by dynamic light scattering: methods and techniques for students." Biochemistry and Molecular Biology Education. 2012;40(6):372-382. doi:10.1002/bmb.20644. https://pubmed.ncbi.nlm.nih.gov/23166025/

• "Dynamic Light Scattering (DLS)." Harvard Medical School Center for Macromolecular Interactions. https://cmi.hms.harvard.edu/dynamic-light-scattering

• Wyatt Technology. "Light Scattering Solutions for Protein Characterization." https://www.wyatt.com/solutions/applications/protein-biophysical-characterization-multi-angle-dynamic-light-scattering.html

• Unchained Labs. "Dynamic Light Scattering (DLS)." https://www.unchainedlabs.com/dynamic-light-scattering/